-
Mashup Score: 2Ovarian Cancer Clinical Brief #3 - 7 month(s) ago
Join us on Twitter for an ovarian cancer clinical brief discussing the emerging role of initial and maintenance therapy with PARPi + IO combinations!Featuring expert faculty Martina Murphy, MD; Eleonora Teplinsky, MD; Mollie Finkel, RN, MSN, WHNP-BC, AOCNP-BC; Gregg Nelson, MD, PhD, FRCSC; and Brian Slomovitz, MD, MS, FACOG.
Source: www.addevent.comCategories: Hem/Oncs, Latest HeadlinesTweet
-
Mashup Score: 3
We hope you can join us on Wednesday, September 13, 2023 at 8pm ET for our chat about raising awareness of gynecologic cancers titled How d…
Source: gyncsm.blogspot.comCategories: Hem/Oncs, Latest HeadlinesTweet
-
Mashup Score: 2Endometrial Cancer Clinical Brief #2 - 10 month(s) ago
Join us on Twitter for an endometrial cancer clinical brief! Launching Wednesday, July 12, 2023 at 6:00 PM EDT, Martina Murphy, MD and Megan Hutchcraft, MD will discuss the monitoring and management of irAEs.
Source: www.addevent.comCategories: Hem/Oncs, Latest HeadlinesTweet
-
Mashup Score: 1Endometrial Cancer Clinical Brief #1 - 10 month(s) ago
Join us on Twitter for the first endometrial cancer clinical brief in this series! Launching Wednesday, June 28, 2023 at 6:00 PM EDT, Martina Murphy, MD & Lindsey McAlarnen, MD, MSc will discuss the treatment of advanced EC.
Source: www.addevent.comCategories: Hem/Oncs, Latest HeadlinesTweet
-
Mashup Score: 2Dr Zeybek on the Investigation of Neoadjuvant Olaparib in Newly Diagnosed BRCA-Mutant Ovarian Cancer - 1 year(s) ago
Burak Zeybek, MD, discusses key results and clinical implications from the phase 1 NOW trial investigating neoadjuvant olaparib in patients with newly diagnosed, BRCA-mutant ovarian cancer.
Source: OncLiveCategories: Hem/Oncs, Latest HeadlinesTweet
-
Mashup Score: 0Opinion | As a Doctor, I Know Being Ready to Die Is an Illusion - 1 year(s) ago
It is easier to search for readiness than to process what its absence means.
Source: www.nytimes.comCategories: Hem/Oncs, Latest HeadlinesTweet
-
Mashup Score: 5Cancer Screening Guidelines | Detecting Cancer Early - 1 year(s) ago
Cancer screening increases the chances of finding certain cancers before a person has symptoms. Learn what screening tests the American Cancer Society recommends.
Source: www.cancer.orgCategories: Hem/Oncs, Latest HeadlinesTweet
-
Mashup Score: 3
As senior associate dean of graduate medical education, Dr. Julia Close works to improve training at UF
Source: Doctor GatorCategories: Hem/Oncs, Latest HeadlinesTweet
-
Mashup Score: 0
Take this survey powered by surveymonkey.com. Create your own surveys for free.
Source: www.surveymonkey.comCategories: Hem/Oncs, Latest HeadlinesTweet-
8/#TumorBoardTuesday #BonumCE #OncTwitter #GynCSM #gynonc #EndometrialCancer #CME🔗https://t.co/uUKmd2Fd6q 🔴#PostTest Q4️⃣ During treatment w pembro + lenva, pt develops grade 3 HTN 🔴What is the most effective mgmt strategy for this patient? (CS = corticosteroid)
-
6/#TumorBoardTuesday #BonumCE #GynCSM #EndometrialCancer #CME 🔗https://t.co/uUKmd2Fd6q 🔴#PostTest Q 2️⃣ 📊During tx w pembro + lenva, pt develops grd 3 diarrhea 🛑Lenva held 💊Loperamide Rx Grade3️⃣diarrhea persists 🔴Which is the appropriate next step for this pt?
-
-
Mashup Score: 0
-
“2/#TumorBoardTuesday #OncTwitter #GynCSM #gynonc #CME🔗https://t.co/bLiLVwKRda 🟢#PreTest Q 1️⃣ 📊Diarrhea, nausea, & vomiting are common GI toxicities associated w pembro + lenvatinib combo therapy 🟢Which other tox may occur if these GI toxicities are not effectively managed?”
Read the original tweet here
Source: TwitterCategories: Hem/Oncs, Latest HeadlinesTweet -
RT @SoMeCME: This week on @SoMeCME: 🔎 #OCBrief #3 - initial & maintenance therapy w/ PARPi + IO combinations: https://t.co/ehG3e5rLqs 👥 @D…